World Investment Advisors

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1652594 SANTA BARBARA, CA

Position in HALO

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$321,728

-$352,214 QoQ

Shares Held

4,978

-50.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

World Investment Advisors holds $5,395,760 across 16 Biotechnology names. HALO ranks #7 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GERN	Geron Corp	1,033,779	$1,540,330
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,820	$812,702
3	REGN	Regeneron Pharmaceuticals, Inc.	845	$652,880
4	RPRX	Royalty Pharma plc	9,949	$477,253
5	MRNA	Moderna, Inc.	6,999	$355,549
6	INCY	Incyte Corp	3,471	$326,690
7	HALO	Halozyme Therapeutics, Inc. This page	4,978	$321,728
8	DMAC	DiaMedica Therapeutics Inc.	36,975	$250,320

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$321,728	4,978	-50.3%	Shares	Sole	2026-04-27
2025-12-31	$673,942	10,014	—	Shares	Sole	2026-03-13
No filing history on record for this holder in this stock.